First Trust Advisors’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-109,388
Closed -$834K 2573
2022
Q1
$834K Sell
109,388
-78,530
-42% -$608K ﹤0.01% 2108
2021
Q4
$1.74M Sell
187,918
-82,676
-31% -$878K ﹤0.01% 1841
2021
Q3
$3.85M Sell
270,594
-55,272
-17% -$858K ﹤0.01% 1477
2021
Q2
$5.42M Buy
+325,866
New +$6.07M 0.01% 1302

Other funds holding ORGO

First Trust Advisors's ORGO Position: Q2 2022 in Review

First Trust Advisors sold out of Organogenesis Holdings (ORGO) in Q2 2022, closing a stake of 109,388 shares — an estimated $834K sold.

First Trust Advisors first reported a position in ORGO in Q2 2021 and held it in 4 quarters. The position peaked at $5.42M in Q2 2021. 146 funds tracked by Wall St. Rank hold ORGO as of Q2 2022.

  • First Trust Advisors reported no remaining Organogenesis Holdings position as of Q2 2022 after selling out during the quarter.
  • First Trust Advisors sold 109,388 Organogenesis Holdings shares in Q2 2022, an estimated $834K.
  • First Trust Advisors first reported a position in Organogenesis Holdings in Q2 2021 and held it in 4 quarters.
  • First Trust Advisors's Organogenesis Holdings position peaked at $5.42M in Q2 2021.
  • 146 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2022.

Based on First Trust Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.